A chronopharmacology-friendly multi-target therapeutics based on AI: the example of therapeutic hypothermia

Author:

Liu Fei,Jiang Xiangkang,Zhang Mao

Abstract

AbstractNowadays, the complexity of disease mechanisms and inadequacy of single-target therapies in restoring the biological system has inevitably instigated the strategy of multi-target therapeutics with the application of hybrid and chimeric drugs. However, the related method is still unable to solve the conflicts between targets or between drugs. With the release of high-precision protein structure prediction artificial intelligence (AI), large-scale high-precision protein structure prediction and docking become possible. In this article, we propose a multi-target drug discovery method. Then we take an example of therapeutic hypothermia (TH). We performed protein structure prediction for all targets of each group by AlphaFold2 and RoseTTAFold. QuickVina 2 is then used for molecular docking of the proteins and drugs. After docking, we use PageRank to get the rank of drugs and drug combinations of each group. Given the differences in the scoring of different proteins, the method can effectively avoid inhibiting beneficial proteins. So it’s friendly to chronopharmacology. This method also have potential in precision medicine for its high compatibility with bioinformatics.

Publisher

Cold Spring Harbor Laboratory

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3